Sector portfolio · Government fund · United Kingdom
Wellcome Trust's Biotech portfolio
Wellcome Trust has backed 13 Biotech startups in rounds we track, $956M between them, shown by the stage each has reached. The best-funded is Kymab.
Funding by segment
- Series C and later$749M6
- Stage not reported$139M4
- Series A$67M3
Where they are based
- United Kingdom6$573M
- United States6$376M
United Kingdom
United StatesFounded
5 without a founding year on record.
Total raised
- Under $1M0
- $1M to $10M1
- $10M to $50M6
- $50M to $250M6
- $250M to $1B0
- $1B and over0
Each dot is a startup: the year it was founded across, the total it has raised up (each line is ten times the one below). Pick a segment to pick it out.
8 of 13 startups shown; the rest have no founding year or amount on record.
- 1 to 2
- 3 to 7
- 8 to 24
- 25 to 99
- 100 and more
- United Kingdom6
- United States6
Startups by country, 2 countries in all.
Segment by segment
Series C and later
6 startups · $749M raised
- KKymabUnited Kingdom$229M
- CMCell MedicaUnited Kingdom$192M
- OBOptiScan BiomedicalUnited States$121M
Integrated DiagnosticsIntegrated Diagnostics develops tools to help physicians diagnose complex diseases with a non-invasive blood test.United States$95M
CellBiosciencesProteinSimple develops and commercializes proprietary systems and consumables for protein analyzis.United States$85M- OOxagenOxagen develops small molecule drugs to treat inflammatory and respiratory diseases.United Kingdom$27M
Stage not reported
4 startups · $139M raised
Chroma TherapeuticsChroma Therapeutics is a biotechnology company located in Oxford/Abingdon, UK.United Kingdom$78M- NBNovacta BiosystemsUnited Kingdom$29M
- KKarunaUnited States$20M
- KKinetaKineta aims at developing edge therapeutics in autoimmune disease, viral disease, and chronic pain areas.United States$13M
Series A
3 startups · $67M raised
- KPKaruna PharmaUnited States$42M
- OOMassUnited Kingdom$18M
- QPQwell PharmaceuticalsQwell Pharmaceuticals develops small molecule drugs that could prevent tumors and excess inflammation of skin cells.-$7.0M
How this map is made. Every startup here works in Biotech and has raised money in a round we track that names Wellcome Trust as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.
More portfolio maps
All portfoliosRaising from investors like Wellcome Trust?
Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.